WO1997028687A1 - Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same - Google Patents

Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same Download PDF

Info

Publication number
WO1997028687A1
WO1997028687A1 PCT/US1997/001967 US9701967W WO9728687A1 WO 1997028687 A1 WO1997028687 A1 WO 1997028687A1 US 9701967 W US9701967 W US 9701967W WO 9728687 A1 WO9728687 A1 WO 9728687A1
Authority
WO
WIPO (PCT)
Prior art keywords
dodecylamine
counter ion
composition
alkylene
salt
Prior art date
Application number
PCT/US1997/001967
Other languages
French (fr)
Inventor
Fernando Del Corral
Percy Jaquess
David Oppong
Original Assignee
Buckman Laboratories International, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buckman Laboratories International, Inc. filed Critical Buckman Laboratories International, Inc.
Priority to SK1019-98A priority Critical patent/SK101998A3/en
Priority to JP52868297A priority patent/JP3939355B2/en
Priority to NZ331248A priority patent/NZ331248A/en
Priority to AT97906516T priority patent/ATE209438T1/en
Priority to BR9707318A priority patent/BR9707318A/en
Priority to EP97906516A priority patent/EP0884944B1/en
Priority to CA002247375A priority patent/CA2247375C/en
Priority to AU21187/97A priority patent/AU724312B2/en
Priority to DE69708610T priority patent/DE69708610T2/en
Publication of WO1997028687A1 publication Critical patent/WO1997028687A1/en
Priority to NO983610A priority patent/NO983610L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/04Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms

Definitions

  • the present invention relates to certain compositions and processes useful for controlling the growth of one or more microorganisms.
  • the novel processes and mixtures of the present invention show unexpected synergistic activity against microorganisms, including bacteria, fungi and algae.
  • the present invention particularly relates to the use of compositions/mixtures comprising an ionene polymer and a salt of dodecylamine.
  • a large number of commercial industrial and agricultural products are subject to microbiological attacks that reduce or destroy their economic value.
  • products that may be subject to such biological fouling are coatings, wood and wood products, agricultural seed, animal hides, textiles, plastics, adhesives, pharmaceuticals, cosmetics, toiletries, lubricants, agrochemicals, petrochemicals, paints, proteinaceous materials, and the like.
  • the storage temperature of these and other products and the products' intrinsic characteristics make them susceptible to the growth of various microorganisms.
  • These microorganisms can be introduced during manufacturing or handling by exposure to air, tanks, pipes, equipment, humans, or any other agent or environment carrying microbiological contaminants.
  • Aqueous systems such as emulsions, suspensions, or solutions containing organic materials, are also highly subject to microbiological attack.
  • aqueous systems include dyes, latexes, paints, surfactants, dispersants, stabilizers, thickeners, adhesives, starches, waxes, proteins, emulsifying agents, detergents, cellulose products, resins, metalworking fluids, cooling tower fluids, paper mill liquors, tanning liquors, and recreational aqueous systems, i.e., pools, spas, etc., and the like.
  • These systems frequently contain relatively large amounts of water, causing them to be well-suited environments for biological growth and thus attack and degradation.
  • Microbiological fouling and degradation of aqueous systems containing organic materials manifests itself by problems such as loss of viscosity, gas formation, objectionable odors, decreased pH, emulsion breaking, color change, and gelling.
  • Slime can reduce yields from industrial processes using aqueous systems and render recreational aqueous systems unsuitable for use.
  • Slime consists of matted deposits of microorganisms, fibers, and debris. It may be stringy, pasty, rubbery, tapioca-like, or hard, and may have a characteristic undesirable odor that is different from that of the aqueous liquid system in which it is formed.
  • the microbiological contaminants involved in slime formation are primarily different species of spore-forming and nonspore-forming bacteria, particularly capsulated forms of bacteria that secrete gelatinous substances that envelop or encase the cells.
  • Slime microorganisms also include filamentous bacteria, filamentous fungi of the mold type, yeasts, and yeast-like organisms.
  • microbiological organisms responsible for biological fouling of various aqueous systems include various bacteria, fungi, mildews, algaes, and the like.
  • various industrial microbicides are used. Workers in the trade have continued to seek improved biocides that have low toxicity and are capable of exhibiting a prolonged biocidal effect against a wide variety of microorganisms at normal use.
  • Increasingly stringent environmental and safety regulations as well as escalating development costs have created the need for new microbicidal agents selected from known safe and economical materials.
  • lonene polymers i.e., cationic polymers containing quaternary nitrogens in the polymer backbone, is one group of biocides used in controlling bacteria and algae in various aqueous systems. See, e.g., A. Rembaum, "Biological Activity of lonene Polymers," Applied Polymer Symposium No. 22, 299-317 (1973) and O.
  • controlling the growth of at least one microorganism includes both the reduction and/or prevention of such growth. It is to be further understood that by “controlling" the growth of at least one microorganism, the growth of at least one microorganism is inhibited. In other words, there is no growth or substantially no growth of at least one microorganism. "Controlling" the growth of at least one microorganism includes maintaining a microorganism population at a desired level (including undetectable levels such as zero population), reducing a microorganism population to a desired level and/or inhibiting or slowing the growth of at least one microorganism. Thus, materials and media susceptible to attack by at least one microorganism are preserved and/or protected from this attack and the resultant deleterious effects.
  • the present invention provides a composition comprising an ionene polymer and a salt of dodecylamine where the components are present in a combined amount synergistically effective to control the growth of at least one microorganism.
  • the present invention also provides a method for controlling the growth of at least one microorganism in or on a material or medium susceptible to attack by the microorganism which comprises the step of adding to the material or medium a composition of the present invention in an amount synergistically effective to control the growth of the microorganism.
  • the synergistically effec ⁇ tive amount varies in accordance with the material or medium to be treated and can, for a particular application, be routinely determined by one skilled in the art.
  • the present invention also embodies the separate addition of an ionene polymer and a salt of dodecylamine to the products, materials or media described above.
  • the components are individually added to the system so that the final amount present at the time of use is that amount synergistically effective to control the growth of at least one microorganism.
  • compositions of the present invention are also useful in preserving or controlling the growth of microorganisms in various types of industrial media or materials susceptible to attack by microorganisms.
  • media or materials include, but are not limited to, dyes, pastes, lumber, leather, textiles, pulp, wood chips, tanning liquor, a paper mill liquor, a polymer emulsion, a paint, paper and other coating and sizing agents, a metalworking fluid, a geological drilling lubricant, petrochemicals, a cooling water system, recreational water, influent plant water, waste water, pasteurizers, retort cookers, a pharmaceutical formulation, and cosmetic and toiletry formulations.
  • composition can also be useful in agrochemical formulations for the purpose of protecting seeds or crops against microbial spoilage.
  • compositions combining an ionene polymer and a salt of dodecylamine demonstrate an unexpected synergistic effect compared to the respective components alone.
  • these compositions achieve superior, i.e. greater than additive, microbicidal activity, even at low concentrations, against a wide variety of microorganisms.
  • microorganisms include fungi, bacteria and algae such as Trichoderma harzianun. Pseudomonas aeru ⁇ inosa and Chlorella pyrenoidosa.
  • the compositions of the present invention have a low toxicity.
  • ionene polymer or mixture of ionene polymers may be used to practice this invention.
  • lonene polymers may be classified according to the repeating unit found in the polymer. The repeating unit results from the reactants used to make the ionene polymer.
  • a first preferred type of ionene polymer comprises the repeating unit of formula I:
  • R ⁇ R 2 , R 3 , and R 4 can be identical or different, and are selected from H, C ⁇ C alkyl optionally substituted with at least one hydroxyl
  • R 1 , R 2 , R 3 and R 4 are all methyl or ethyl.
  • the group "A" is a divalent radical selected from C,-C 10 alkylene, C 2 -C 10 alkenylene, 0,-0, 0 alkynylene, C,-C,o hydroxyalkylene, symmetric or asymmetric di-C,-C 10 -alkylenether, arylene, arylene-C,-C,o-alkylene, or 0,-0, 0 - alkylenearyl-C,-C,o alkylene.
  • A is a divalent C,-C 5 alkylene, C 2 - C 5 alkenylene, C 2 -C 5 hydroxyalkylene, or symmetric di-C 2 -C 5 -alkylenether, and most preferably "A" is -CH 2 CH 2 CH 2 -, -CH 2 CH(OH)CH 2 - or -CH 2 CH 2 OCH 2 CH 2 -.
  • the group “B” is a divalent radical selected from 0,-0, 0 alkylene, C 2 -C 10 alkenylene, C 2 -C 10 alkynylene, 0,-0, 0 hydroxyalkylene, arylene, arylene-C,- 0, 0 -alkylene, or Ci-C ⁇ -alkylenearyl-C ⁇ Cio-alkylene.
  • "B” is C,-C 5 ; alkylene, C 2 -C 5 alkenylene, C 2 -C 5 hydroxyalkylene, arylene, arylene-C,-C 5 - alkyiene, or C ⁇ Cs-alkylenearyl-C ⁇ Cs-alkylene.
  • B is a divalent radical selected from 0,-0, 0 alkylene, C 2 -C 10 alkenylene, C 2 -C 10 alkynylene, 0,-0, 0 hydroxyalkylene, arylene, arylene-C,- 0, 0 -alky
  • the counter ion, X 2* is a divalent counter ion, two monovalent counter ions, or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the repeating unit which forms the ionene polymer backbone.
  • X 2' is two monovalent anions selected from a halide anion and a trihalide anion and more preferably, chloride or bromide, lonene polymers having trihalide counter ions are described in U.S. Patent No. 3,778,476, the disclosure of which is incorporated here by reference.
  • the ionene polymers having the repeating unit of formula I may be prepared by a number of known methods. One method is to react a diamine of the formula R 1 R 2 N-B-NR 1 R 2 with a dihalide of the formula X-A-X. lonene polymers having this repeating unit and methods for their preparation are described, for example, in U.S. Patents Nos. 3,874,870; 3,931,319; 4,025,627; 4,027,020; 4,506,081; and 5,093,078, the disclosure of each of which is inco ⁇ orated here by reference. The biological activity of ionene polymers having the repeating unit of formula I is also described in these patents.
  • a particularly preferred ionene polymer is poly[oxyethylene- (dimethyliminio)ethylene(dimethyliminio)ethylene] dichloride.
  • R 1 , R 2 , R 3 and R 4 are each methyl, A is
  • BUSAN® 77 and WSCP® are biocides used primarily in aqueous systems, including metalworking fluids, for tnicroorganism control.
  • ionene polymer having a repeating unit of formula I is the ionene polymer where R 1 , R 2 , R 3 and R 4 are each methyl, A is -CH 2 CH(OH)CH 2 -, B is -CH 2 CH 2 -and X 2 " is 2 Of.
  • This ionene polymer is a reaction product of N.N.N'.N'-tetramethyl-l ⁇ -ethanediamine with
  • (chloromethyl)oxirane has an average molecular weight of 1 ,000-5,000.
  • the polymer is available from Buckman Laboratories, Inc. as BUSAN® 79 product and WSCP® 11 product, which are each 60% aqueous solutions of the polymer.
  • a second type of ionene polymer comprises the repeating unit of
  • X ' is a monovalent counter ion, one half of a divalent counter ion, or a fraction of a polyvalent counter ion sufficient to balance the cationic charge of the repeating unit which forms the ionene polymer.
  • X ' may be, for example, a halide or trihalide anion, and X * is preferably chloride or bromide.
  • the ionene polymers having the repeating unit of formula II may be prepared by known methods. One method is to react an amine of the formula R 1 R 2 NH with a haloepoxide such as epichlorohydrin. lonene polymers having the repeating unit of formula II are described, for example, in U.S. Patents Nos. 4,111 ,679 and 5,051,124, the disclosure of each of which is incorporated here by reference. The biological activity of ionene polymers having the repeating unit of formula II is also described in these patents. Preferred ionene polymers having the repeating unit of formula II are those where R 1 and R 2 are each methyl, A is -CH 2 CH(OH)CH 2 -, and X- is Cl " .
  • This polymer is obtained as a reaction product of N-dimethylamine with (chloromethyl)oxirane, and has an average molecular weight of 2,000-10,000.
  • the polymer is available from Buckman Laboratories, Inc. as the BUSAN® 1055 product, a 50% aqueous dispersion of the polymer.
  • ionene polymer having the repeating unit of formula II is obtained as a reaction product of dimethylamine with elchlorohydrin, where R 1 and R 2 are each methyl, A is and -CH 2 CH(OH)CH 2 - and X " is Cl".
  • This ionene polymer has a 5,000-10,000 average molecular weight, and is available from Buckman Laboratories, Inc. in a 50% aqueous solution as the BUSAN® 1055 product.
  • a third type of ionene polymer comprises a repeating unit of formula III:
  • the group B' is ⁇ - [CH 2 -CH(OH)-CH 2 -N + R' 2 -(CHR , ) n -NH-C(0)-NH]-, X " ⁇ or ⁇ -[(CHR') n -N * R 2 - CH 2 -CH(OH)-CH 2 ]-, X ⁇ .
  • the variables n and p independently vary from 2 to 12.
  • Each R' is independently hydrogen or a lower alkyl group.
  • X 2" is a divalent counter ion, two monovalent counter ions, or a fraction of a polyvalent counter Ion sufficient to balance the cationic charge in the group R.
  • X is a monovalent counter ion, one half of a divalent counter ion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the group B'.
  • R' is hydrogen or C,-C 4 alkyl, n is 2-6, and p is 2-6. Most preferably, R' is hydrogen or methyl, n is 3 and p is 2.
  • Preferred counter ions for X 2' and X are the same as those discussed above for formulae I and ll.
  • the polymers of formula III are derived by known methods from bis-(dialkylaminoalkyl) ureas, which are also known as urea diamines. lonene polymers of the formula III, methods of their preparation, and their biological activities are described in U.S. Patent No. 4,506,081 , the disclosure of which is incorporated here by reference.
  • Preferred ionene polymers having the repeating unit of formula III are those where R is urea diamine and B' is CH 2 CH(OH)CH 2 , and X ' is Cl " .
  • Available from Buckman Laboratories, Inc., ASTAT product and BL® 1090 product are 50% aqueous dispersions of this ionene polymer.
  • the ionene polymer is obtained as a reaction product of N,N'-bis-[1-(3-(dimethylamino)- propyl)] urea and epichlorohydrin, such ionene polymer having an average
  • lonene polymers comprising the repeating units of formulae I, ll, and III may also be cross-linked with primary, secondary or other polyfunctional amines using means known in the art. lonene polymers can be cross-linked either through the quaternary nitrogen atom or through another functional group attached to the polymer backbone or to a side chain.
  • the cross-linking co- reactants listed are ammonia, primary amines, alkylenediamines, polyglycolamines, piperazines, heteroaromatic diamines and aromatic diamines.
  • Patent No. 5,051,124 also describes methods of inhibiting the growth of
  • a preferred cross-linked ionene polymer has a repeating unit of formula
  • This ionene polymer is obtained as a reaction product of dimethylamine with epichlorohydrin, cross-linked with ethylenediamine, where R 1 and R 2 are each methyl, A is -CH 2 CH(OH)CH 2 - and X * is Cl " .
  • the ionene polymer has a
  • Another preferred cross-linked ionene polymer has a repeating unit of
  • the ionene polymer is cross-linked with ammonia. This ionene polymer
  • Buckman Laboratories, Inc. products BUSAN® 1099 or BUBOND® 65 are 25% aqueous dispersions of a cross-linked ionene polymer having
  • R 1 and R 2 are each methyl, A is -CH 2 CH(OH)CH 2 -, X " is Cl " , and the cross-linking agent is monomethylamine.
  • This preferred ionene polymer has a molecular weight of approximately 10,000-100,000.
  • the ionene polymers comprising the repeating units of formulae I, II, or
  • ionene III may also be capped, i.e., have a specific end group.
  • Capping may be achieved by means known in the art. For example, an excess of either reactant used to make the ionene polymer can be employed to provide a capping group. Altematively, a calculated quantity of a monofunctional tertiary amine or monofunctional substituted or unsubstituted alkyl halide can be reacted with an ionene polymer to obtain a capped ionene polymer, lonene polymers can be capped at one or both ends. Capped ionene polymers and their microbicidal properties are described in U.S. Patents Nos. 3,931,319 and 5,093,073, the disclosure of each of which is incorporated here by reference.
  • the salts of dodecylamine employed in the present invention preferably have the following general formula:
  • X is an anion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the dodecylamine.
  • X is preferably the conjugate base of an organic or inorganic acid, i.e., X is derived from an organic or inorganic acid by loss of an ionizable proton.
  • suitable organic acids are the mono- and di-carboxylic acids; suitable inorganic acids include the hydrohalide acids, such as hydrochloric acid.
  • X is derived from an acyclic, cyclic, or aromatic mono- or
  • the carboxylic acid preferably has up to ten carbon atoms. If cyclic or aromatic, the ring may contain one or more heteroatoms, such as N, 0, or S.
  • the carboxylic acid may also be substituted by any suitable substituent that does not adversely effect the activity of the inventive compositions.
  • suitable substituents include alkyl groups, substituted alkyl groups, alkenyl groups, substituted alkenyl groups, amino groups, oxo groups, halogen atoms, etc.
  • carboxylic acid groups include: acetyl, propionyl, butyryl, citral, lactyl, valeryl, phthalyl, succinyl, octanoyl, nonanoyl, formyl, sorbyl, oxalyl, lauryl, and benzoyl.
  • organic acid groups may also be used in the present invention.
  • the dodecyl group of the dodecylamine may be branched or unbranched, i.e., straight chain. Preferably, the dodecyl group is unbranched.
  • the dodecyl group may be unsubstituted or substituted by one or more substituents that do not adversely effect the activity of the inventive salts.
  • suitable substituents include alkyl groups, alkenyl groups, alkoxy groups, aryl groups, aralkyl groups, hydroxy groups, oxo groups (to form a ketone), acid groups and derivatives thereof, such as esters and amides, and halogen atoms.
  • the dodecyl group is unsubstituted.
  • One or more of the hydrogen atoms bound to the nitrogen atom may be replaced by a suitable substituent to give a secondary, tertiary, or quaternary
  • amine salt of dodecylamine Preferably, a primary amine salt of dodecylamine
  • carboxylic acid salts of dodecylamine are particulariy preferred in the practice of the present invention: dodecylamine acetate, dodecylamine propionate, dodecylamine butyrate, dodecylamine citrate, dodecylamine lactate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine octanoate, dodecylamine nonanate, dodecylamine formate, dodecylamine sorbate, dodecylamine oxalate, dodecylamine iaurate, dodecylamine benzoate, dodecylamine 2- hydroxybenzoate, dodecylamine 3-hydroxybenzoate, or dodecylamine 4- hydroxybenzoate.
  • dodecylamine acetate dodecylamine propionate, dodecylamine butyrate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine citrate, and dodecylamine lactate.
  • dodecylamine acetate dodecylamine propionate
  • dodecylamine butyrate dodecylamine valerate
  • dodecylamine phthalate dodecylamine succinate
  • dodecylamine citrate dodecylamine lactate.
  • dodecylamine lactate dodecylamine lactate
  • the salts of dodecylamine are preferably prepared by reacting
  • Suitable acids groups are available in their acid or salt form either commercially from laboratory supply houses or can be prepared from readily
  • the synthesis of the amine salts generally can be carried out in a solvent which may be a solvent for at least one of the reactants but which is generally a solvent for the desired product.
  • Preferred solvent systems include inorganic acids and organic acids or alcohols. Most preferred is acetic acid.
  • the temperature of reaction may be readily determined by one skilled in the art depending on the particular reactants employed. Preferably the temperature of reaction varies from 40°C to 110 ⁇ C or more, more preferably the temperature of the reaction is between 70°C and 100°C.
  • the reaction is
  • reaction is complete when the pH meter indicates that the limiting reactant has been neutralized.
  • reaction is stirred for 30 min to 2 hours, preferably for about 1 to 2 hours.
  • the reaction product can be worked up using well-known techniques to isolate and purify the desired salt of dodecylamine. Excess reactants and any solids formed during the reaction can be filtered off, and the filtrate evaporated to yield the crude product. In cases where the desired salt compound is a solid, the product of the reaction can be recrystallized from an appropriate solvent to yield a more pure compound. It should be noted, however, that both pure and crude salts of dodecylamine can be used for in the compositions and methods of this in ⁇ vention.
  • the preparation of the salts is not limited to the exact process or steps described above. Any of procedures known to the art which yield the desired end product may be used.
  • the particular salt of dodecylamine employed may be selected based on the compatibility of these compounds with the materials or media. Compatibility is determined by criteria such as solubility in the fluid system and lack of reactivity with the fluid or material or media in question. The compatibility is readily determined by one ordinary skill by adding the salt of dodecylamine to the material or media to be used. When used in a fluid system it is preferable that the salt of dodecylamine be freely soluble in the particular fluid resulting in a uniform solution or dispersion.
  • components (a) and (b) are used in synergistically effective amounts.
  • the weight ratios of (a) to (b) vary depending on the type of microorganisms and material or media to which the composition is applied. One skilled in the art can readily determine without undue experimentation, the appropriate weight ratios for a specific application.
  • the ratio of component (a) to component (b) preferably ranges from 1:99 to 99:1, more preferably from 1 :30 to 30: 1 , and most preferably 1 :2 to 2: 1.
  • the composition may be prepared in liquid form by dissolving the composition in water or in an organic solvent, or in dry form by adsorbing onto a suitable vehicle or it can be compounded into a tablet form.
  • the preservative may be prepared in an emulsion form by emulsifying it in water, or if necessary, by adding a surfactant. Additional chemicals, such as insecticides, may be added to the foregoing preparations depending upon the intended use of the preparation.
  • composition could vary depending upon the intended use.
  • the composition could vary depending upon the intended use.
  • composition could be applied by spraying or brushing onto the material or product.
  • the material or product in question could also be treated by dipping in a suitable formulation of the composition.
  • the composition In a liquid or liquid-like medium, the composition could be added into the medium by pouring, or by metering with a suitable device so that a solution or a dispersion of the composition could be produced.
  • Qa Concentration of compound A in parts per million, acting alone, which produced an end point.
  • Qb Concentration of compound B in parts per million, acting alone, which produced an end point.
  • QA Concentration of compound A in parts per million, in the mixture, which produced an end point.
  • QB Concentration of compound B in parts per million, in the mixture, which produced an end point.
  • Table 1 Synergistic and additive effect of polyquat combinations with dodeclyamine acetate versus selected algae species.
  • an effective fungicidal, bactericidal or algicidal response can be obtained when the synergistic combination is employed in concentrations ranging preferably from about 0.01 ppm to about 1% (i.e., about 10,000 ppm) of the ionene polymer, more preferably about 0.1 to about 5000 ppm, and most preferably about 0.1 ppm to about 1000 ppm, and preferably from about 0.01 to about 5000p pm of the salt of dodecylamine, more preferably about 0.1 to about 2000 ppm, and most preferably about 0.1 to about 1000 ppm.

Abstract

Compositions comprising an ionene polymer and a salt of dodecylamine are disclosed which are synergistically effective compared to the respective components alone in controlling the growth of microorganisms in or on a material or medium. Methods to control of growth of microorganisms with the use of the compositions of the present invention are also disclosed.

Description

SYNERGISTIC ANTIMICROBIAL COMPOSITIONS
CONTAINING AN IONENE POLYMER AND A SALT OF
DODECYLAMINE AND METHODS OF USING THE SAME
The present invention relates to certain compositions and processes useful for controlling the growth of one or more microorganisms. The novel processes and mixtures of the present invention show unexpected synergistic activity against microorganisms, including bacteria, fungi and algae. The present invention particularly relates to the use of compositions/mixtures comprising an ionene polymer and a salt of dodecylamine.
A large number of commercial industrial and agricultural products are subject to microbiological attacks that reduce or destroy their economic value. Examples of products that may be subject to such biological fouling are coatings, wood and wood products, agricultural seed, animal hides, textiles, plastics, adhesives, pharmaceuticals, cosmetics, toiletries, lubricants, agrochemicals, petrochemicals, paints, proteinaceous materials, and the like. The storage temperature of these and other products and the products' intrinsic characteristics make them susceptible to the growth of various microorganisms. These microorganisms can be introduced during manufacturing or handling by exposure to air, tanks, pipes, equipment, humans, or any other agent or environment carrying microbiological contaminants.
Aqueous systems, such as emulsions, suspensions, or solutions containing organic materials, are also highly subject to microbiological attack. Such aqueous systems include dyes, latexes, paints, surfactants, dispersants, stabilizers, thickeners, adhesives, starches, waxes, proteins, emulsifying agents, detergents, cellulose products, resins, metalworking fluids, cooling tower fluids, paper mill liquors, tanning liquors, and recreational aqueous systems, i.e., pools, spas, etc., and the like. These systems frequently contain relatively large amounts of water, causing them to be well-suited environments for biological growth and thus attack and degradation. Microbiological fouling and degradation of aqueous systems containing organic materials manifests itself by problems such as loss of viscosity, gas formation, objectionable odors, decreased pH, emulsion breaking, color change, and gelling.
Another objectionable phenomenon occurring in aqueous industrial, commercial, or recreational systems is slime formation. Slime can reduce yields from industrial processes using aqueous systems and render recreational aqueous systems unsuitable for use. Slime consists of matted deposits of microorganisms, fibers, and debris. It may be stringy, pasty, rubbery, tapioca-like, or hard, and may have a characteristic undesirable odor that is different from that of the aqueous liquid system in which it is formed. The microbiological contaminants involved in slime formation are primarily different species of spore-forming and nonspore-forming bacteria, particularly capsulated forms of bacteria that secrete gelatinous substances that envelop or encase the cells. Slime microorganisms also include filamentous bacteria, filamentous fungi of the mold type, yeasts, and yeast-like organisms.
The microbiological organisms responsible for biological fouling of various aqueous systems include various bacteria, fungi, mildews, algaes, and the like. To control deterioration or degradation caused by microorganisms, various industrial microbicides are used. Workers in the trade have continued to seek improved biocides that have low toxicity and are capable of exhibiting a prolonged biocidal effect against a wide variety of microorganisms at normal use. Increasingly stringent environmental and safety regulations as well as escalating development costs have created the need for new microbicidal agents selected from known safe and economical materials.
Primary alkyl carboxylic acid salts are known to have surfactant properties arising from the hydrophobic apolar hydrocarbon chain and the hydrophilic polar amine acid group; however, the utility and effectiveness of these compounds as microbicides and herbicides has not been known or appreciated in the prior art. lonene polymers, i.e., cationic polymers containing quaternary nitrogens in the polymer backbone, is one group of biocides used in controlling bacteria and algae in various aqueous systems. See, e.g., A. Rembaum, "Biological Activity of lonene Polymers," Applied Polymer Symposium No. 22, 299-317 (1973) and O. May, Polymeric Antimicrobial Agents" in Disinfection, Sterilization, and Preservation, S. Block, ed., 322-333 (Lea & Febiger, Philadelphia, 1991 ). lonene polymers have a variety of uses in aqueous systems such as microbicides, bactericides, and algicides as well as controlling, even preventing, biofiim and slime formation. U.S. Patents Nos. 3,874,870; 3,931 ,319; 4,027,020; 4,089,977; 4,111 ,679; 4,506,081; 4,581 ,058; 4,778,813; 4,970,211 ; 5,051,124; 5,093,078; 5,142,002; and 5,128,100, the disclosure of each of which is incorporated here by reference, give various examples of these polymers, their preparation, and their uses. While generally effective as algicides and bactericides, most ionene polymers are less effective against many groups of fungi.
Accordingly, there is a need in the art for a microbicidal composition that overcomes these and other problems.
SUMMARY OF THE INVENTION
It is therefore an object of this invention to provide a microbicidal composition capable of controlling the growth of at least one microorganism, particularly fungi, bacteria and algae over prolonged periods of time. It is an additional object to provide such compositions which are economical to use. Methods of controlling the growth of at least one microorganism are also objects of this invention.
According to the present invention, controlling the growth of at least one microorganism includes both the reduction and/or prevention of such growth. It is to be further understood that by "controlling" the growth of at least one microorganism, the growth of at least one microorganism is inhibited. In other words, there is no growth or substantially no growth of at least one microorganism. "Controlling" the growth of at least one microorganism includes maintaining a microorganism population at a desired level (including undetectable levels such as zero population), reducing a microorganism population to a desired level and/or inhibiting or slowing the growth of at least one microorganism. Thus, materials and media susceptible to attack by at least one microorganism are preserved and/or protected from this attack and the resultant deleterious effects.
In accordance with these and other objects, the present invention provides a composition comprising an ionene polymer and a salt of dodecylamine where the components are present in a combined amount synergistically effective to control the growth of at least one microorganism.
The present invention also provides a method for controlling the growth of at least one microorganism in or on a material or medium susceptible to attack by the microorganism which comprises the step of adding to the material or medium a composition of the present invention in an amount synergistically effective to control the growth of the microorganism. The synergistically effec¬ tive amount varies in accordance with the material or medium to be treated and can, for a particular application, be routinely determined by one skilled in the art.
The present invention also embodies the separate addition of an ionene polymer and a salt of dodecylamine to the products, materials or media described above. According to this embodiment, the components are individually added to the system so that the final amount present at the time of use is that amount synergistically effective to control the growth of at least one microorganism.
The compositions of the present invention are also useful in preserving or controlling the growth of microorganisms in various types of industrial media or materials susceptible to attack by microorganisms. Such media or materials include, but are not limited to, dyes, pastes, lumber, leather, textiles, pulp, wood chips, tanning liquor, a paper mill liquor, a polymer emulsion, a paint, paper and other coating and sizing agents, a metalworking fluid, a geological drilling lubricant, petrochemicals, a cooling water system, recreational water, influent plant water, waste water, pasteurizers, retort cookers, a pharmaceutical formulation, and cosmetic and toiletry formulations.
The composition can also be useful in agrochemical formulations for the purpose of protecting seeds or crops against microbial spoilage.
Additional objects and advantages of the invention will be set forth in part in the description which follows, and in part will be apparent from the description, or may be learned by the practice of the invention. The objects and advantages of the invention may be realized and obtained by means of the elements and combinations particularly pointed out in the claims.
It is to be understood that both the foregoing general description and the following general description are exemplary and explanatory only and are not restrictive of the present invention as claimed.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
When two chemical microbicides are combined into one product or added separately three results are possible:
1 ) The resulting product would produce an additive (neutral) effect.
2) The products in the product would produce an antagonistic effect, or
3) The chemicals in the product would produce a synergistic effect.
An additive effect has no economic advantage over the individual components. The antagonistic effect would produce a negative impact. Only synergistic effect, which is less likely than either an additive or antagonistic effect, would produce a positive effect and therefore possess economic advantages. It is known in the microbicidal literature that there is no theoretical method to anticipate additive, antagonistic or synergistic effects when two biocides are mixed to yield a new formulation. Nor is there a method to predict the relative proportions of the different biocides required to produce one of the three effects described above.
The inventive microbicidal compositions combining an ionene polymer and a salt of dodecylamine demonstrate an unexpected synergistic effect compared to the respective components alone. Thus, these compositions achieve superior, i.e. greater than additive, microbicidal activity, even at low concentrations, against a wide variety of microorganisms. Examples of these microorganisms include fungi, bacteria and algae such as Trichoderma harzianun. Pseudomonas aeruαinosa and Chlorella pyrenoidosa. Preferably, the compositions of the present invention have a low toxicity.
Any ionene polymer or mixture of ionene polymers may be used to practice this invention. lonene polymers may be classified according to the repeating unit found in the polymer. The repeating unit results from the reactants used to make the ionene polymer.
A first preferred type of ionene polymer comprises the repeating unit of formula I:
Figure imgf000008_0001
In this formula, R\ R2, R3, and R4 can be identical or different, and are selected from H, C^C alkyl optionally substituted with at least one hydroxyl
group, and benzyl optionally substituted on the benzene moiety with at least
one CrC20 alkyl group. Preferably, R1, R2, R3 and R4 are all methyl or ethyl. The group "A" is a divalent radical selected from C,-C10 alkylene, C2-C10 alkenylene, 0,-0,0 alkynylene, C,-C,o hydroxyalkylene, symmetric or asymmetric di-C,-C10-alkylenether, arylene, arylene-C,-C,o-alkylene, or 0,-0,0- alkylenearyl-C,-C,o alkylene. Preferably, "A" is a divalent C,-C5 alkylene, C2- C5 alkenylene, C2-C5 hydroxyalkylene, or symmetric di-C2-C5-alkylenether, and most preferably "A" is -CH2CH2CH2-, -CH2CH(OH)CH2- or -CH2CH2OCH2CH2-.
The group "B" is a divalent radical selected from 0,-0,0 alkylene, C2-C10 alkenylene, C2-C10 alkynylene, 0,-0,0 hydroxyalkylene, arylene, arylene-C,- 0,0-alkylene, or Ci-C^-alkylenearyl-C^Cio-alkylene. Preferably, "B" is C,-C5; alkylene, C2-C5 alkenylene, C2-C5 hydroxyalkylene, arylene, arylene-C,-C5- alkyiene, or C^Cs-alkylenearyl-C^Cs-alkylene. Most preferably "B" is
-CHjCrKj", -CH2CH2CH2-1 -CH2CH2CH2CH2-, or -Cn (Cn2) CH2-.
The counter ion, X2*, is a divalent counter ion, two monovalent counter ions, or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the repeating unit which forms the ionene polymer backbone. Preferably, X2' is two monovalent anions selected from a halide anion and a trihalide anion and more preferably, chloride or bromide, lonene polymers having trihalide counter ions are described in U.S. Patent No. 3,778,476, the disclosure of which is incorporated here by reference.
The ionene polymers having the repeating unit of formula I may be prepared by a number of known methods. One method is to react a diamine of the formula R1R2N-B-NR1R2 with a dihalide of the formula X-A-X. lonene polymers having this repeating unit and methods for their preparation are described, for example, in U.S. Patents Nos. 3,874,870; 3,931,319; 4,025,627; 4,027,020; 4,506,081; and 5,093,078, the disclosure of each of which is incoφorated here by reference. The biological activity of ionene polymers having the repeating unit of formula I is also described in these patents.
Among the ionene polymers with a repeating unit of formula I, a particularly preferred ionene polymer is poly[oxyethylene- (dimethyliminio)ethylene(dimethyliminio)ethylene] dichloride. In this ionene polymer of formula I, R1, R2, R3 and R4 are each methyl, A is
Figure imgf000010_0001
B is -CH2CH2- and X2" is 2 Cl", and the average molecular weight is 1,000-5,000. This ionene polymer is available from Buckman laboratories, Inc. of Memphis, Tennessee as BUSAN® 77 product or WSCP® product, which are each 60% aqueous dispersions of the polymer. BUSAN® 77 and WSCP® are biocides used primarily in aqueous systems, including metalworking fluids, for tnicroorganism control.
Another particularly preferred ionene polymer having a repeating unit of formula I is the ionene polymer where R1, R2, R3 and R4 are each methyl, A is -CH2CH(OH)CH2-, B is -CH2CH2-and X2" is 2 Of. This ionene polymer is a reaction product of N.N.N'.N'-tetramethyl-l^-ethanediamine with
(chloromethyl)oxirane, and has an average molecular weight of 1 ,000-5,000. The polymer is available from Buckman Laboratories, Inc. as BUSAN® 79 product and WSCP® 11 product, which are each 60% aqueous solutions of the polymer.
A second type of ionene polymer comprises the repeating unit of
formula II:
Figure imgf000011_0001
(ll)
In formula II, the definitions of R\ R2, and A are the same as those defined above for formula I. X' is a monovalent counter ion, one half of a divalent counter ion, or a fraction of a polyvalent counter ion sufficient to balance the cationic charge of the repeating unit which forms the ionene polymer. X' may be, for example, a halide or trihalide anion, and X* is preferably chloride or bromide.
The ionene polymers having the repeating unit of formula II may be prepared by known methods. One method is to react an amine of the formula R1R2NH with a haloepoxide such as epichlorohydrin. lonene polymers having the repeating unit of formula II are described, for example, in U.S. Patents Nos. 4,111 ,679 and 5,051,124, the disclosure of each of which is incorporated here by reference. The biological activity of ionene polymers having the repeating unit of formula II is also described in these patents. Preferred ionene polymers having the repeating unit of formula II are those where R1 and R2 are each methyl, A is -CH2CH(OH)CH2-, and X- is Cl". This polymer is obtained as a reaction product of N-dimethylamine with (chloromethyl)oxirane, and has an average molecular weight of 2,000-10,000. The polymer is available from Buckman Laboratories, Inc. as the BUSAN® 1055 product, a 50% aqueous dispersion of the polymer.
Another preferred ionene polymer having the repeating unit of formula II is obtained as a reaction product of dimethylamine with elchlorohydrin, where R1 and R2 are each methyl, A is and -CH2CH(OH)CH2- and X" is Cl". This ionene polymer has a 5,000-10,000 average molecular weight, and is available from Buckman Laboratories, Inc. in a 50% aqueous solution as the BUSAN® 1055 product.
A third type of ionene polymer comprises a repeating unit of formula III:
Figure imgf000012_0001
CH3 X CH3
I I wherein R is - N+ — Q — N+ - or
I I
CH3 CH3
CH3 CH 2 CH3
\ / \ /
N* N+
/ \ / \
CH? CH X The group Q is -(CHR')P- -CH2-CH=CH-CH2-, -CH2-CH2-0-CH2-CH2-, -CH2-CH(OH)-CH2, or -(CHR')n-NH-C(0)-NH(CHR,)π-. The group B' is {- [CH2-CH(OH)-CH2-N+R'2-(CHR,)n-NH-C(0)-NH]-, X"} or {-[(CHR')n-N*R2- CH2-CH(OH)-CH2]-, X}. The variables n and p independently vary from 2 to 12. Each R' is independently hydrogen or a lower alkyl group. X2" is a divalent counter ion, two monovalent counter ions, or a fraction of a polyvalent counter Ion sufficient to balance the cationic charge in the group R. X is a monovalent counter ion, one half of a divalent counter ion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the group B'.
Preferably, R' is hydrogen or C,-C4 alkyl, n is 2-6, and p is 2-6. Most preferably, R' is hydrogen or methyl, n is 3 and p is 2. Preferred counter ions for X2' and X are the same as those discussed above for formulae I and ll.
The polymers of formula III are derived by known methods from bis-(dialkylaminoalkyl) ureas, which are also known as urea diamines. lonene polymers of the formula III, methods of their preparation, and their biological activities are described in U.S. Patent No. 4,506,081 , the disclosure of which is incorporated here by reference.
Preferred ionene polymers having the repeating unit of formula III are those where R is urea diamine and B' is CH2CH(OH)CH2, and X' is Cl". Available from Buckman Laboratories, Inc., ASTAT product and BL® 1090 product are 50% aqueous dispersions of this ionene polymer. The ionene polymer is obtained as a reaction product of N,N'-bis-[1-(3-(dimethylamino)- propyl)] urea and epichlorohydrin, such ionene polymer having an average
molecular weight of 2,000- 15,000, preferably 3,000-7,000. lonene polymers comprising the repeating units of formulae I, ll, and III may also be cross-linked with primary, secondary or other polyfunctional amines using means known in the art. lonene polymers can be cross-linked either through the quaternary nitrogen atom or through another functional group attached to the polymer backbone or to a side chain.
Cross-linked ionene polymers, prepared using cross-linking co-reactaπts, are disclosed in U.S. Patent No. 3,738,945 and Reissue U.S. Patent No. 28,808, the disclosure of each which is incoφorated here by reference. The Reissue Patent describes the cross-linking of ionene polymers
prepared by the reaction of dimethylamine and epichlorohydrin. The cross-linking co- reactants listed are ammonia, primary amines, alkylenediamines, polyglycolamines, piperazines, heteroaromatic diamines and aromatic diamines.
U.S. Patent No. 5, 051,124, the disclosure of which is incoφorated here by reference, describes cross-linked ionene polymers resulting from the reaction of dimethylamine, a polyfunctional amine, and epichlorohydrin. U.S.
Patent No. 5,051,124 also describes methods of inhibiting the growth of
microorganisms using such cross-linked ionene polymers. Other examples of various cross-linked ionene polymers and their properties are provided in U.S. Patents Nos. 3,894,946; 3,894,947; 3,930,977; 4,104,161 ; 4,164,521 ; 4,147,627; 4,166,041; 4,606,773; and 4,769,155, the disclosures of each of
which is incoφorated here by reference.
A preferred cross-linked ionene polymer has a repeating unit of formula
II. This ionene polymer is obtained as a reaction product of dimethylamine with epichlorohydrin, cross-linked with ethylenediamine, where R1 and R2 are each methyl, A is -CH2CH(OH)CH2- and X* is Cl". The ionene polymer has a
100,000-500,000 average molecular weight, and is available from Buckman Laboratories, Inc. in a 50% aqueous dispersion as BUSAN® 1157 product.
Another preferred cross-linked ionene polymer has a repeating unit of
formula II, where R1 and R2 are each methyl, A is -CH2CH(OH)CH2-, and X" is
Cl". The ionene polymer is cross-linked with ammonia. This ionene polymer
has a molecular weight of approximately 100,000-500,000, and is available
from Buckman Laboratories, Inc. in a 50% aqueous dispersion sold as the BL® 1155 product.
Buckman Laboratories, Inc. products BUSAN® 1099 or BUBOND® 65 are 25% aqueous dispersions of a cross-linked ionene polymer having
repeating units of formula II, where R1 and R2 are each methyl, A is -CH2CH(OH)CH2-, X" is Cl", and the cross-linking agent is monomethylamine.
This preferred ionene polymer has a molecular weight of approximately 10,000-100,000. The ionene polymers comprising the repeating units of formulae I, II, or
III may also be capped, i.e., have a specific end group. Capping may be achieved by means known in the art. For example, an excess of either reactant used to make the ionene polymer can be employed to provide a capping group. Altematively, a calculated quantity of a monofunctional tertiary amine or monofunctional substituted or unsubstituted alkyl halide can be reacted with an ionene polymer to obtain a capped ionene polymer, lonene polymers can be capped at one or both ends. Capped ionene polymers and their microbicidal properties are described in U.S. Patents Nos. 3,931,319 and 5,093,073, the disclosure of each of which is incorporated here by reference.
Each of the above ionene polymers and products identified by trade name is available from Buckman Laboratories International, Inc. of Memphis Tennessee.
The salts of dodecylamine employed in the present invention preferably have the following general formula:
C12H25NH3 X* in which X is an anion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the dodecylamine. X is preferably the conjugate base of an organic or inorganic acid, i.e., X is derived from an organic or inorganic acid by loss of an ionizable proton. Illustrative examples of suitable organic acids are the mono- and di-carboxylic acids; suitable inorganic acids include the hydrohalide acids, such as hydrochloric acid. Preferably, X is derived from an acyclic, cyclic, or aromatic mono- or
dicarboxylic acid. The carboxylic acid preferably has up to ten carbon atoms. If cyclic or aromatic, the ring may contain one or more heteroatoms, such as N, 0, or S.
The carboxylic acid may also be substituted by any suitable substituent that does not adversely effect the activity of the inventive compositions. Illustrative examples of suitable substituents include alkyl groups, substituted alkyl groups, alkenyl groups, substituted alkenyl groups, amino groups, oxo groups, halogen atoms, etc.
Illustrative examples of useful carboxylic acid groups include: acetyl, propionyl, butyryl, citral, lactyl, valeryl, phthalyl, succinyl, octanoyl, nonanoyl, formyl, sorbyl, oxalyl, lauryl, and benzoyl. One of ordinary skill will recognize that other organic acid groups may also be used in the present invention.
The dodecyl group of the dodecylamine may be branched or unbranched, i.e., straight chain. Preferably, the dodecyl group is unbranched.
The dodecyl group may be unsubstituted or substituted by one or more substituents that do not adversely effect the activity of the inventive salts. Illustrative examples of suitable substituents include alkyl groups, alkenyl groups, alkoxy groups, aryl groups, aralkyl groups, hydroxy groups, oxo groups (to form a ketone), acid groups and derivatives thereof, such as esters and amides, and halogen atoms. Preferably, the dodecyl group is unsubstituted. One or more of the hydrogen atoms bound to the nitrogen atom may be replaced by a suitable substituent to give a secondary, tertiary, or quaternary
amine salt of dodecylamine. Preferably, a primary amine salt of dodecylamine
is employed in the inventive compositions.
The following carboxylic acid salts of dodecylamine are particulariy preferred in the practice of the present invention: dodecylamine acetate, dodecylamine propionate, dodecylamine butyrate, dodecylamine citrate, dodecylamine lactate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine octanoate, dodecylamine nonanate, dodecylamine formate, dodecylamine sorbate, dodecylamine oxalate, dodecylamine iaurate, dodecylamine benzoate, dodecylamine 2- hydroxybenzoate, dodecylamine 3-hydroxybenzoate, or dodecylamine 4- hydroxybenzoate. More particulariy preferred of these compounds are dodecylamine acetate, dodecylamine propionate, dodecylamine butyrate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine citrate, and dodecylamine lactate. Most particulariy preferred is
dodecylamine acetate.
The salts of dodecylamine are preferably prepared by reacting
dodecylamine with the desired acid in the presence of a suitable solvent. Suitable acids groups are available in their acid or salt form either commercially from laboratory supply houses or can be prepared from readily
available starting materials using well-known literature methods. The synthesis of the amine salts generally can be carried out in a solvent which may be a solvent for at least one of the reactants but which is generally a solvent for the desired product. Preferred solvent systems include inorganic acids and organic acids or alcohols. Most preferred is acetic acid.
The temperature of reaction may be readily determined by one skilled in the art depending on the particular reactants employed. Preferably the temperature of reaction varies from 40°C to 110βC or more, more preferably the temperature of the reaction is between 70°C and 100°C. The reaction is
allowed to proceed until complete, as shown, for example, by a pH meter (the reaction is complete when the pH meter indicates that the limiting reactant has been neutralized). Generally, the reaction is stirred for 30 min to 2 hours, preferably for about 1 to 2 hours.
After the reaction is complete, the reaction product can be worked up using well-known techniques to isolate and purify the desired salt of dodecylamine. Excess reactants and any solids formed during the reaction can be filtered off, and the filtrate evaporated to yield the crude product. In cases where the desired salt compound is a solid, the product of the reaction can be recrystallized from an appropriate solvent to yield a more pure compound. It should be noted, however, that both pure and crude salts of dodecylamine can be used for in the compositions and methods of this in¬ vention. The preparation of the salts is not limited to the exact process or steps described above. Any of procedures known to the art which yield the desired end product may be used.
The particular salt of dodecylamine employed may be selected based on the compatibility of these compounds with the materials or media. Compatibility is determined by criteria such as solubility in the fluid system and lack of reactivity with the fluid or material or media in question. The compatibility is readily determined by one ordinary skill by adding the salt of dodecylamine to the material or media to be used. When used in a fluid system it is preferable that the salt of dodecylamine be freely soluble in the particular fluid resulting in a uniform solution or dispersion.
As described above, components (a) and (b) are used in synergistically effective amounts. The weight ratios of (a) to (b) vary depending on the type of microorganisms and material or media to which the composition is applied. One skilled in the art can readily determine without undue experimentation, the appropriate weight ratios for a specific application. The ratio of component (a) to component (b) preferably ranges from 1:99 to 99:1, more preferably from 1 :30 to 30: 1 , and most preferably 1 :2 to 2: 1.
Depending upon the specific application, the composition may be prepared in liquid form by dissolving the composition in water or in an organic solvent, or in dry form by adsorbing onto a suitable vehicle or it can be compounded into a tablet form. The preservative may be prepared in an emulsion form by emulsifying it in water, or if necessary, by adding a surfactant. Additional chemicals, such as insecticides, may be added to the foregoing preparations depending upon the intended use of the preparation.
The mode as well as the rates of application of the composition of this invention could vary depending upon the intended use. The composition could
be applied by spraying or brushing onto the material or product. The material or product in question could also be treated by dipping in a suitable formulation of the composition. In a liquid or liquid-like medium, the composition could be added into the medium by pouring, or by metering with a suitable device so that a solution or a dispersion of the composition could be produced.
The synergistic activity of the combinations described above has been confirmed using standard laboratory techniques as illustrated below.
Synergism was demonstrated by the method described by Kull, E.C., Eisman,
P.C, Sylwestrwicz, H.D., and Mayer, R.L., Applied Microbiology 9: 538-541
(1961):
QA Qa + QB/Qb wherein
Qa = Concentration of compound A in parts per million, acting alone, which produced an end point.
Qb = Concentration of compound B in parts per million, acting alone, which produced an end point.
QA = Concentration of compound A in parts per million, in the mixture, which produced an end point. QB = Concentration of compound B in parts per million, in the mixture, which produced an end point.
When the sum of QA Qa and QB/Qb is greater than one, antagonism is indicated and when the sum is equal to one, additivity is indicated. When the sum of this value is less than one, synergism exists.
This procedure for demonstrating synergism of the compositions of this invention is a widely used and acceptable procedure. More detailed information is provided in the article by Kull et al. Further information concerning this procedure is contained in U.S. Patent No. 3,231,509, the disclosure of which is herein incoφorated by reference.
Based on the above criteria, a synergistic activity against bacteria, fungi and algae is observed when an ionene polymer is combined with a salt of dodecylamine. Examples showing synergistic results can be found in the following Tables.
Table 1 : Synergistic and additive effect of polyquat combinations with dodeclyamine acetate versus selected algae species.
Figure imgf000022_0001
Qa = DDA alone
QA = DDA in combination Qb = WSCP alone
QB = WSCP in combination
Table 2. Synergistic and additive effect of BUSAN 1055 with dodecylamine propionate versus selected algae species
Quantities Producing End Points (ppm)
Test Organism
Qa QA Qb QB QA/Qa QB/Qb (QA/QaWQB/Qb)
10 2.5 5 2.5 0.25 0.5 0.75
Chlorella pyrenodiosa 10 5 5 1.25 0.5 0-25 0.75
10 5 5 0.6 0.5 0.12 0.62
10 5 5 0.3 0.5 0.06 0.44
10 5 5 0.15 0.5 0.03 0.53
Scenesdesmus obliquos 5 2.5 5 2.5 0.5 0.5 1.0
Coccomyxa simplex 10 5 2.5 1.25 0.5 0.5 1.0
Qa = Dodecylamine propionate alone
QA = Dodeclyamine propionate in combination
Qb = BUSAN 1055 alone
QB = BUSAN 1055 in combination
In general, however, an effective fungicidal, bactericidal or algicidal response can be obtained when the synergistic combination is employed in concentrations ranging preferably from about 0.01 ppm to about 1% (i.e., about 10,000 ppm) of the ionene polymer, more preferably about 0.1 to about 5000 ppm, and most preferably about 0.1 ppm to about 1000 ppm, and preferably from about 0.01 to about 5000p pm of the salt of dodecylamine, more preferably about 0.1 to about 2000 ppm, and most preferably about 0.1 to about 1000 ppm.

Claims

WHAT IS CLAIMED IS:
1. A composition comprising (a) an ionene polymer and (b) a salt of dodecylamine, wherein components (a) and (b) are present in a combined amount synergistically effective to control the growth of at least one microorganism.
2. The composition of claim 1 , wherein the microorganism is selected from bacteria, fungi, or algae.
3. The composition of claim 1 , wherein the ionene polymer comprises the repeating unit of formula I:
Figure imgf000024_0001
wherein
R\ R2, R3, and R4 are identical or different, and are selected from hydrogen, C,-C20 alkyl optionally substituted with at least one hydroxyl group, and benzyl optionally substituted on the benzene moiety with at least one C,-C20 alkyl group;
A is a divalent radical selected from C,-C,0 alkylene, C2-C,0 alkenylene, C2- C,0 alkynylene, C,-C10 hydroxyalkylene, symmetric or asymmetric di-C,-C,0- alkylenether, arylene, arylene-C,-C,0-alkylene, or C,-Cι0-alkylenearyl-C,-C,0- alkylene;
B is a divalent radical selected from C,-C10 alkylene, C2-C,0 alkenylene, C2- C,0 alkynylene, C,-C,0 hydroxyalkylene, arylene, arylene-C,-C,o-alkylene, or C,- C10-alkylenearyl-C,-Ci0-alkylene; X2" is a divalent counter ion, two monovalent counter ions or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the repeating unit which forms the ionene polymer backbone.
4. The composition of claim 1 , wherein the ionene polymer comprises the repeating unit of formula II:
Figure imgf000025_0001
wherein
R1 and R2 are identical or different, and are selected from hydrogen, C,-C2o alkyl optionally substituted with at least one hydroxyl group, and benzyl optionally substituted on the benzene moiety with at least one C1-C20 alkyl group;
A is a divalent radical selected from C,-C,0 alkylene, C2-C,0 alkenylene, C2- C,0 alkynylene, C,-C,0 hydroxyalkylene, symmetric or asymmetric di-C,-C,0- alkylenether, arylene, arylene-C,-C,0-alkylene, or
Figure imgf000025_0002
alkyiene; and
X' is a monovalent counter ion, one-half of a divalent counter ion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge of the repeating unit which forms the ionene polymer.
5. The composition of claim 1 , wherein the ionene polymer comprises the repeating unit of formula III:
Figure imgf000025_0003
CH3 X CH3
I I wherein R is - N* — Q — N+ - or
I I
CH3 CH3
CH3 CH2 --' ' ■ ■2 CH3
\ / \ /
N* N*
/ \ / \
CH2 CH2 X ;
Q is -(CHR')p-, -CH2-CH=CH-CH2-, -CH2-CH2-0-CH2-CH2-, -CH2-CH(OH)-CH2, or -(CHR,)n-NH-C(0)-NH(CHR')n-; B' is {-[CH2-CH(OH)-CH2-N+R, 2-(CHR')n-NH-C(0)-NH]-, X} or {-[(CHR')n-N+R2-CH2-CH(OH)-CH2]-, X-}; wherein n and p independently vary from 2 to 12; R' is independently hydrogen or a lower alkyl group; X2' is a divalent counter ion, two monovalent counter ions or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the group R; and
X' is a monovalent counter ion, one-half of a divalent counter ion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the group B\
6. The composition of claim 1 , wherein said salt of dodecylamine is an organic salt of dodecylamine.
7. The composition of claim 6, wherein said organic salt of dodecylamine is a carboxylic acid salt of dodecylamine.
8. The composition of claim 7, wherein said carboxylic acid is selected from the group consisting of acyclic, cyclic or aromatic mono- or dicarboxylic acids having up to ten carbon atoms.
9. The composition of claim 8, wherein said carboxylic acid salt of dodecylamine is selected from the group consisting of dodecylamine acetate, dodecylamine propionate, dodecylamine butyrate, dodecylamine citrate, dodecylamine lactate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine octanoate, dodecylamine nonanate, dodecylamine formate, dodecylamine sorbate, dodecylamine oxalate, dodecylamine laurate, dodecylamine benzoate, dodecylamine 2-hydroxybenzoate, dodecylamine 3-hydroxybenzoate, or dodecylamine 4-hydroxybenzoate.
10. The composition of claim 9, wherein said carboxylic acid salt of dodecylamine is dodecylamine acetate, dodecylamine propionate, dodecylamine butyrate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine citrate, or dodecylamine lactate.
11. The composition of claim 1 , wherein said salt of dodecylamine is an inorganic salt of dodecylamine.
12. The composition of claim 11 , wherein said inorganic salt of dodecylamine is dodecylamine hydrochloride.
13. The composition of claim 8, wherein said carboxylic acid salt of dodecylamine has the following general formula:
C,2H25NH3 X" wherein X is an acyclic, cyclic, or aromatic mono- or dicarboxylic acid group having up to ten carbon atoms and which is unsubstituted or substituted.
14. The composition of claim 1 , wherein the weight ratio of (a) to (b) is from about 1 : 99 to about 99:1.
15. The composition of claim 14, wherein the weight ratio of (a) to (b) is from about 1 :30 to about 30:1.
16. The composition of claim 15, wherein the weight ratio of (a) to (b) is from about 1 :2 to about 2:1.
17. A method of controlling the growth of at least one microorganism in or on a material or medium susceptible to attack by microorganism comprising the step of adding to the material or medium a composition comprising (a) an ionene polymer and (b) a salt of dodecylamine in a combined amount synergistically effective to control the growth of at least one microorganism.
18. The method of claim 17, wherein the microorganism is selected from bacteria, fungi, and algae.
19. The method of claim 17, wherein the material or medium is wood pulp, wood chips, lumber, paint, leather, adhesive and coatings, animal hides, tanning liquor, paper mill liquor, a metalworking fluid, petrochemical, pharmaceutical formulation, cooling water, recreational water, dyes, clays, mineral slurries, cationic surfactants and formulations with cationic surfactants, influent water, waste water, pasteurizers, retort cookers, a cosmetic or toiletry formulation, textiles, a geological drilling lubricant or an agrochemical composition for crop or seed protection.
20. The method of claim 17, wherein the material or medium is in the form of a solid, dispersion, emulsion, solution or a solid.
21. The method of claim 17, wherein the ionene polymer comprises the repeating unit of formula I:
Figure imgf000029_0001
wherein
R1, R2, R3, and R4 are identical or different, and are selected from hydrogen, C,-C20 alkyl optionally substituted with at least one hydroxyl group, and benzyl optionally substituted on the benzene moiety with at least one C,-C20 alkyl group;
A is a divalent radical selected from C,-C,0 alkylene, C2-C10 alkenylene, C2- C,0 alkynylene, C,-C10 hydroxyalkylene, symmetric or asymmetric di-C,-C10- alkylenether, arylene, arylene-C1-C,0-alkylene, or C,-C10-alkylenearyl-C,-Ci0- alkylene;
B is a divalent radical selected from C,-C10 alkylene, C2-C,0 alkenylene, C2- C,0 alkynylene, C,-C,0 hydroxyalkylene, arylene, arylene-C,-C,0-alkylene, or C,- C,0-alkylenearyl-C,-Cι0-alkylene;
X2' is a divalent counter ion, two monovalent counter ions or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the repeating unit which forms the ionene polymer backbone.
22. The method of claim 17, wherein the ionene polymer comprises the repeating unit of formula II:
Figure imgf000029_0002
wherein
R1 and R2 are identical or different, and are selected from hydrogen, C,-C20 alkyl optionally substituted with at least one hydroxyl group, and benzyl optionally substituted on the benzene moiety with at least one C,-C20 alkyl group;
A is a divalent radical selected from C,-C10 alkylene, C2-C,0 alkenylene, C2- C10 alkynylene, C,-C,0 hydroxyalkylene, symmetric or asymmetric di-C,-C,0- alkylenether, arylene, arylene-C,-C10-alkylene, or
Figure imgf000030_0001
alkylene; and
X" is a monovalent counter ion, one-half of a divalent counter ion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge of the repeating unit which forms the ionene polymer.
23. The method of claim 17, wherein the ionene polymer comprises the repeating unit of formula III:
Figure imgf000030_0002
CH3 X CH3
I I wherein R is - N+ — Q — N+ - or
I I
CH3 CH3
CH32 — — CH2 CH3
\ / \ /
N+ N+
/ \ / \
C H2 C π2 a- ■
Q is -(CHR')p-, -CH2-CH=CH-CH2- -CH2-CH2-0-CH2-CH2-, -CH2-CH(OH)-CH2, or -(CHR,)n-NH-C(0)-NH(CHR,)π-;
B' is {-[CH2-CH(OH)-CH2-N+R'2-(CHR,)n-NH-C(0)-NH]-, X} or H(CHR*)n-N+R2-CH2-CH(OH)-CH2]-, X"}. wherein n and p independently vary from 2 to 12;
R' is independently hydrogen or a lower alkyl group;
X2" is a divalent counter ion, two monovalent counter ions or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the group R; and
X" is a monovalent counter ion, one-half of a divalent counter ion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the group B\
24. The method of claim 17, wherein said salt of dodecylamine is an organic salt of dodecylamine.
25. The method of claim 24, wherein said organic salt of dodecylamine is a carboxylic acid salt of dodecylamine.
26. The method of claim 25, wherein said carboxylic acid is selected from the group consisting of acyclic, cyclic or aromatic mono- or dicarboxylic acids having up to ten carbon atoms.
27. The method of claim 26, wherein said carboxylic acid salt of dodecylamine is selected from the group consisting of dodecylamine acetate, dodecylamine propionate, dodecylamine butyrate, dodecylamine citrate, dodecylamine lactate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine octanoate, dodecylamine nonanate, dodecylamine formate, dodecylamine sorbate, dodecylamine oxalate, dodecylamine laurate, dodecylamine benzoate, dodecylamine 2-hydroxybenzoate, dodecylamine 3-hydroxybenzoate, or dodecylamine 4-hydroxybenzoate.
28. The method of claim 27, wherein said carboxylic acid salt of dodecylamine is dodecylamine acetate, dodecylamine propionate, dodecylamine butyrate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine citrate, or dodecylamine lactate.
29. The method of claim 17, wherein said salt of dodecylamine is an inorganic salt of dodecylamine.
30. The method of claim 29, wherein said inorganic salt of dodecylamine is dodecylamine hydrochloride.
31. The method of claim 26, wherein said carboxylic acid salt of dodecylamine has the following general formula:
C12H25NrVX- wherein R is an acyclic, cyclic, or aromatic mono- or dicarboxylic acid group having up to ten carbon atoms and which is unsubstituted or substituted.
32. The method of claim 17, wherein the weight ratio of (a) to (b) is from about 1 : 99 to about 99:1.
33. The method of claim 32, wherein the weight ratio of (a) to (b) is from about 1 : 30 to about 30:1.
34. The method of claim 33, wherein the weight ratio of (a) to (b) is from about 1:2 to about 2:1.
PCT/US1997/001967 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same WO1997028687A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SK1019-98A SK101998A3 (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
JP52868297A JP3939355B2 (en) 1996-02-07 1997-02-06 Synergistic fungicide composition containing ionene polymer and dodecylamine salt and method of use thereof
NZ331248A NZ331248A (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
AT97906516T ATE209438T1 (en) 1996-02-07 1997-02-06 SYNERGISTIC ANTIMICROBIAL COMPOSITIONS CONTAINING AN IONIC POLYMER AND A DODECYLAMINE SALT AND METHODS OF USE THEREOF
BR9707318A BR9707318A (en) 1996-02-07 1997-02-06 Microbicidal composition and method to control the growth of at least one microorganism
EP97906516A EP0884944B1 (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
CA002247375A CA2247375C (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
AU21187/97A AU724312B2 (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
DE69708610T DE69708610T2 (en) 1996-02-07 1997-02-06 SYNERGISTIC ANTIMICROBIAL COMPOSITIONS CONTAINING AN IONENE POLYMER AND A DODECYLAMINE SALT AND METHOD FOR THEIR USE
NO983610A NO983610L (en) 1996-02-07 1998-08-06 Synergistic anti-microbial compositions containing the ionic polymer and a salt of dodecylamine, as well as a process for using said compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1129096P 1996-02-07 1996-02-07
US60/011,290 1996-02-07

Publications (1)

Publication Number Publication Date
WO1997028687A1 true WO1997028687A1 (en) 1997-08-14

Family

ID=21749727

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/001967 WO1997028687A1 (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same

Country Status (17)

Country Link
US (2) US5843865A (en)
EP (1) EP0884944B1 (en)
JP (1) JP3939355B2 (en)
CN (1) CN1105496C (en)
AR (1) AR005764A1 (en)
AT (1) ATE209438T1 (en)
AU (1) AU724312B2 (en)
BR (1) BR9707318A (en)
CA (1) CA2247375C (en)
CZ (1) CZ233698A3 (en)
ES (1) ES2166066T3 (en)
MX (1) MX9806356A (en)
NO (1) NO983610L (en)
NZ (1) NZ331248A (en)
SK (1) SK101998A3 (en)
WO (1) WO1997028687A1 (en)
ZA (1) ZA971009B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013715A1 (en) * 1997-09-16 1999-03-25 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof
WO2005014687A1 (en) * 2003-08-06 2005-02-17 Basf Aktiengesellschaft Epichlorohydrin amine polymers used for treating the surface of leather
WO2006026166A1 (en) * 2004-08-26 2006-03-09 Bausch & Lomb Incorporated Compositions containing trialkanolamine alkoxylate buffer
US8829055B2 (en) 2006-03-23 2014-09-09 Kao Corporation Biofilm formation inhibitor composition
WO2019244464A1 (en) * 2018-06-22 2019-12-26 パナソニック株式会社 Organic salt, hydroxy-radical sensor including same, and detection medium

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL131205A0 (en) * 1997-02-26 2001-01-28 Lilly Co Eli Process for preparing pharmaceutical compounds
WO2000066175A2 (en) 1999-04-30 2000-11-09 Slil Biomedical Corporation Conjugates as therapies for cancer and prostate diseases
NZ515140A (en) * 1999-04-30 2003-07-25 Slil Biomedical Corp Conformationally restricted polyamine analogs as disease therapies for cancer, epilepsy, alzheimers, infections, grafts and others
AU776573B2 (en) * 1999-08-17 2004-09-16 Ipsilon Pools (Proprietary) Limited A biocidal composition and a method of treating water
US6379563B1 (en) 2000-01-19 2002-04-30 Albemarle Corporation Alkylamines as biofilm deactivation agents
US6419838B1 (en) 2000-01-19 2002-07-16 Albemarle Corporation Synergistic combinations of oxidizing agents and alkylamines for biofilm control and deactivation
US6514458B1 (en) * 2000-02-25 2003-02-04 Ge Betz, Inc. Method for removing microbes from surfaces
JP3784609B2 (en) * 2000-03-31 2006-06-14 日華化学株式会社 Antibacterial agent for fiber and antibacterial fiber product
CA2409386A1 (en) * 2000-06-02 2001-12-13 Avecia Inc. Treatment of circulating water systems
AU2001297817A1 (en) 2000-11-08 2002-11-25 Eli Lilly And Company Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
NZ526821A (en) * 2001-01-18 2005-02-25 Genzyme Corp Ionene polymers and their use as antimicrobial agents
JP3542940B2 (en) * 2001-04-27 2004-07-14 日華化学株式会社 Disinfectant, antibacterial agent and antibacterial material
JP2005506354A (en) * 2001-10-16 2005-03-03 スリル バイオメディカル コーポレイション Oligoamine compounds and their derivatives for cancer treatment
US20030228373A1 (en) * 2002-01-22 2003-12-11 Lonza Inc. Composition including a triamine and a biocide and a method for inhibiting the growth of microorganisms with the same
WO2004046109A2 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Ionene oligomers and polymers
US20040175352A1 (en) * 2003-03-06 2004-09-09 David Oppong Microbicidal compositions including an ionene polymer and 2,4,4-trichloro-2-hydroxydiphenyl ether, and methods of using the same
EP1796746B1 (en) 2004-10-07 2011-05-04 E.I. Du Pont De Nemours And Company Polysaccharide-based polymer tissue adhesive for medical use
JP2008100964A (en) * 2006-10-20 2008-05-01 Kao Corp Biofilm formation inhibitor composition
CN101541857B (en) * 2006-11-27 2012-12-12 阿克塔马克斯手术器材有限责任公司 Multi-functional polyalkylene oxide, hydrogel tissue adhesives
US20090035249A1 (en) * 2007-08-02 2009-02-05 Bhatia Sujata K Method of inhibiting proliferation of Escherichia coli
WO2009064963A2 (en) * 2007-11-14 2009-05-22 E. I. Du Pont De Nemours And Company Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
WO2010059279A2 (en) * 2008-11-19 2010-05-27 E. I. Du Pont De Nemours And Company Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
EP2416811B1 (en) 2009-04-09 2015-09-09 Actamax Surgical Materials LLC Hydrogel tissue adhesive having reduced degradation time
ES2574238T3 (en) 2009-07-02 2016-06-16 Actamax Surgical Materials Llc Tissue hydrogel adhesive for medical use
WO2011002956A1 (en) 2009-07-02 2011-01-06 E. I. Du Pont De Nemours And Company Aldehyde-functionalized polysaccharides
US8796242B2 (en) 2009-07-02 2014-08-05 Actamax Surgical Materials, Llc Hydrogel tissue adhesive for medical use
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
WO2015017340A2 (en) 2013-07-29 2015-02-05 Actamax Surgical Materials, Llc Low swell tissue adhesive and sealant formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3140976A (en) * 1960-12-16 1964-07-14 Armour Pharma Quaternary ammonium germicide
WO1995012976A1 (en) * 1993-11-12 1995-05-18 Bruce Green Disinfectant composition

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3003915A (en) * 1961-10-10 Method of destroying lactobacilli em-
US28808A (en) * 1860-06-19 Warped surfaces
US3778476A (en) * 1970-05-11 1973-12-11 California Inst Of Techn Polymeric organic halogen salts
USRE28808E (en) * 1972-02-04 1976-05-11 American Cyanamid Company Polyquaternary flocculants
US3738945A (en) * 1972-02-04 1973-06-12 H Panzer Polyquaternary flocculants
US3894947A (en) * 1973-04-02 1975-07-15 American Cyanamid Co Process for treating industrial wastes
US3894946A (en) * 1973-04-02 1975-07-15 American Cyanamid Co Process for treating industrial wastes
US4025627A (en) * 1973-12-18 1977-05-24 Millmaster Onyx Corporation Microbiocidal polymeric quaternary ammonium compounds
US3874870A (en) * 1973-12-18 1975-04-01 Mill Master Onyx Corp Microbiocidal polymeric quarternary ammonium compounds
US3931319A (en) * 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4027020A (en) * 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4089977A (en) * 1976-11-24 1978-05-16 Kewanee Industries Polymeric anti-microbial agent
US4164521A (en) * 1977-02-07 1979-08-14 American Cyanamid Company Mixtures of polycationic and polyanionic polymers for scale control
US4147627A (en) * 1977-02-07 1979-04-03 American Cyanamid Company Process for scale control using mixtures of polycationic and polyanionic polymers
US4111679A (en) * 1977-08-17 1978-09-05 Chemed Corporation Polyquaternary compounds for the control of microbiological growth
US4166041A (en) * 1977-12-15 1979-08-28 American Cyanamid Company Process for magnesium scale control using mixtures of polycationic and polyanionic polymers
US4104161A (en) * 1978-04-18 1978-08-01 Nalco Chemical Company Method for treating aqueous wastes containing at least 1% proteinaceous matter
US4778813A (en) * 1981-07-07 1988-10-18 Buckman Laboratories International, Inc. Polymeric quaternary ammonium compounds, their preparation and use
US4506081A (en) * 1982-09-02 1985-03-19 Buckman Laboratories, Inc. Polymeric quaternary ammonium compounds and their uses
US4581058A (en) * 1982-09-02 1986-04-08 Buckman Laboratories, Inc. Polymeric quaternary ammonium compounds and their uses
US4606773A (en) * 1984-12-10 1986-08-19 Nalco Chemical Company Emulsification of alkenyl succinic anhydride sizing agents
US4970211A (en) * 1985-05-20 1990-11-13 Buckman Laboratories International, Inc. Ionene polymeric compositions, their preparation and use
US4769155A (en) * 1987-08-19 1988-09-06 Nalco Chemical Company Turbidity reduction
CH673545A5 (en) * 1987-10-02 1990-03-15 Industrieorientierte Forsch
DE3840103C2 (en) * 1988-11-28 1994-10-06 Bayrol Chem Fab Gmbh Method for sterilizing and de-aerating water
US4960590A (en) * 1989-02-10 1990-10-02 Buckman Laboratories International, Inc. Novel polymeric quaternary ammonium trihalides
US5128100A (en) * 1989-10-12 1992-07-07 Buckman Laboratories, Intl., Inc. Process for inhibiting bacterial adhesion and controlling biological fouling in aqueous systems
US5051124A (en) * 1989-10-24 1991-09-24 Buckman Laboratories International, Inc. Microbicidal compositions of dimethylamine-epichlorohydrin amines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3140976A (en) * 1960-12-16 1964-07-14 Armour Pharma Quaternary ammonium germicide
WO1995012976A1 (en) * 1993-11-12 1995-05-18 Bruce Green Disinfectant composition

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013715A1 (en) * 1997-09-16 1999-03-25 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof
US5929073A (en) * 1997-09-16 1999-07-27 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing dodecylmorpholine a salt thereof and dodecylamine or a salt thereof
AU745268B2 (en) * 1997-09-16 2002-03-14 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or salt thereof
WO2005014687A1 (en) * 2003-08-06 2005-02-17 Basf Aktiengesellschaft Epichlorohydrin amine polymers used for treating the surface of leather
US7728072B2 (en) 2003-08-06 2010-06-01 Basf Aktiengesellschaft Epichlorohydrin amine polymers used for treating the surface of leather
WO2006026166A1 (en) * 2004-08-26 2006-03-09 Bausch & Lomb Incorporated Compositions containing trialkanolamine alkoxylate buffer
US7629386B2 (en) 2004-08-26 2009-12-08 Bausch + Lomb Incorporated Compositions containing trialkanolamine alkoxylate buffer
US8829055B2 (en) 2006-03-23 2014-09-09 Kao Corporation Biofilm formation inhibitor composition
WO2019244464A1 (en) * 2018-06-22 2019-12-26 パナソニック株式会社 Organic salt, hydroxy-radical sensor including same, and detection medium

Also Published As

Publication number Publication date
ES2166066T3 (en) 2002-04-01
AR005764A1 (en) 1999-07-14
JP2000504690A (en) 2000-04-18
CZ233698A3 (en) 1998-12-16
BR9707318A (en) 1999-04-13
CA2247375A1 (en) 1997-08-14
NO983610D0 (en) 1998-08-06
MX9806356A (en) 1998-10-31
CN1210442A (en) 1999-03-10
CN1105496C (en) 2003-04-16
CA2247375C (en) 2004-03-30
NO983610L (en) 1998-10-07
ATE209438T1 (en) 2001-12-15
NZ331248A (en) 2000-03-27
SK101998A3 (en) 1998-12-02
ZA971009B (en) 1997-10-30
US6103666A (en) 2000-08-15
AU724312B2 (en) 2000-09-14
US5843865A (en) 1998-12-01
AU2118797A (en) 1997-08-28
JP3939355B2 (en) 2007-07-04
EP0884944B1 (en) 2001-11-28
EP0884944A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
EP0884944B1 (en) Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
US5776960A (en) Synergistic antimicrobial compositions containing an ionene polymer and a pyrithione salt and methods of using the same
US5866016A (en) Methods and compositions for controlling biofouling using combinations of an ionene polymer and a salt of dodecylamine
ZA200506601B (en) Microbicidal compositions including an ionene polymer and 2,4,4'-trichloro-2'-hydroxydiphenyl ether and methods of using the same
AU631750B2 (en) Biocide composition
EP0741518A1 (en) Synergistic antimicrobial compositions containing methylene-bis(thiocyanate) and an organic acid
JP2000502705A (en) Synergistic antibacterial composition comprising 1-hydroxymethylpyrazole and preservative
CA2259384C (en) Methods and compositions for controlling biofouling using combinations of an ionene polymer and a salt of dodecylamine
JP4347421B2 (en) Combination microbicide of propiconazole and dodecylamine or dodecylamine salt
JP4387587B2 (en) Synergistic antimicrobial composition containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof
AU9750201A (en) Synergistic antimicrobial compositions containing an ionene polymer and a pyrithione salt and methods of using the same
AU766899B2 (en) Synergistic antimicrobial compositions containing methylene-bis(thiocyanate) and an organic acid
CA2069453A1 (en) Biocide composition

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97192098.2

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PV1998-2336

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 101998

Country of ref document: SK

ENP Entry into the national phase

Ref document number: 2247375

Country of ref document: CA

Ref document number: 2247375

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 331248

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PA/A/1998/006356

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1997906516

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV1998-2336

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1997906516

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1998-2336

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 1997906516

Country of ref document: EP